combination therapy

OBL Corner

Read more about OBL Corner
134 views

News

First-Line Biosimilar-Based Triplet Effective in HER2-Positive Gastric Cancer

07/08/2020

A first-line triplet regimen consisting of pembrolizumab, biosimilar trastuzumab (Herzuma), and chemotherapy is effective in patients with HER2-positive advanced gastric cancer, according to the results of a phase...

A...

07/08/2020

Journal of Clinical Pathways

News

Isatuximab Combination Effective in Myeloma and Soft-Tissue Plasmacytomas

06/22/2020

Isatuximab plus pomalidomide and dexamethasone (Isa-Pd) significantly prolongs progression-free survival (PFS) and improves overall response rate (ORR) compared with pomalidomide plus dexamethasone alone (Pd) in...

...

06/22/2020

Journal of Clinical Pathways

News

Venetoclax-Based Time-Limited Therapy Well Tolerated, Effective in CLL

06/10/2020

Zanubrutinib plus venetoclax and obinutuzumab is well tolerated and achieves rapid undetectable minimal residual disease (MRD) in patients with chronic lymphocytic leukemia (CLL), according to a presentation at the...

...

06/10/2020

Journal of Clinical Pathways

Research in Review

Internal Radiotherapy Combined With Chemo in Colorectal Liver Metastasis

08/09/2017

JCP Editors

A recent study combined and analyzed data from three trials regarding the use of first-line chemotherapy plus selective internal radiotherapy in patients with colorectal cancer and liver metastases, published in The...

A...

08/09/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Survival in a Subtype of AML

08/04/2017

JCP Editors

Addition of a multi-targeted kinase inhibitor to standard chemotherapy improves outcomes in patients with acute myeloid leukemia (AML) and a specific mutation, according to research published in The New England...

...

08/04/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Works Better in AML Patients With Activated NK Cells

08/03/2017

JCP Editors

The presence of natural killer cells can help keep acute myeloid leukemia (AML) in remission in patients treated with a combination therapy, according to a recent study. ----- Related Content Better AML Outcomes...

The...

08/03/2017

Journal of Clinical Pathways

Research in Review

ADT Plus Combination Therapy Improves Outcomes in Metastatic Prostate Cancer

07/28/2017

JCP Editors

A combination regimen plus androgen-deprivation therapy prolongs overall survival (OS) and radiographic progression-free survival (PFS) in newly diagnosed patients with metastatic, castration-sensitive prostate...

A...

07/28/2017

Journal of Clinical Pathways

Research in Review

Triplet Combination Shows Durable Responses in Advanced Multiple Myeloma

07/17/2017

JCP Editors

Patients with heavily treated multiple myeloma showed rapid and durable responses to a novel treatment combination, according to a recent study published in Blood (July 2017;...

...

07/17/2017

Journal of Clinical Pathways

Research in Review

Adjuvant Ovarian Function Suppression Improves Breast Cancer Treatment Outcomes

06/29/2017

JCP Editors

In younger women with hormone receptor (HR)-positive breast cancer, ovarian function suppression (OFS) after surgery drives large improvements in breast cancer-free interval when combined with drug therapy, according...

In...

06/29/2017

Journal of Clinical Pathways